Dr. Mihir Raval, MD

Claim this profile

New York Oncology Hematology, P.C.

Studies Multiple Myeloma
Studies Follicular Lymphoma
4 reported clinical trials
12 drugs studied

Area of expertise

1

Multiple Myeloma

Mihir Raval, MD has run 2 trials for Multiple Myeloma.

2

Follicular Lymphoma

Mihir Raval, MD has run 1 trial for Follicular Lymphoma. Some of their research focus areas include:

EZH2 positive
CNG positive
CNG negative

Affiliated Hospitals

Image of trial facility.

New York Oncology Hematology, P.C.

Image of trial facility.

New York Oncology Hematology, PC

Clinical Trials Mihir Raval, MD is currently running

More about Mihir Raval, MD

Clinical Trial Related

7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Mihir Raval, MD has experience with

  • Lenalidomide
  • Rituximab
  • Tazemetostat
  • Belantamab Mafodotin
  • Pomalidomide Plus Low Dose Dexamethasone
  • Brentuximab Vedotin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mihir Raval, MD specialize in?

Is Mihir Raval, MD currently recruiting for clinical trials?

Are there any treatments that Mihir Raval, MD has studied deeply?

What is the best way to schedule an appointment with Mihir Raval, MD?

What is the office address of Mihir Raval, MD?

Is there any support for travel costs?